Keith Goldan
Director of Finance/CFO at SYNDAX PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-06-29
Keith Goldan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2023-05-04 | - |
| Director of Finance/CFO | 2022-06-12 | - | |
| Treasurer | 2022-06-12 | - |
Career history of Keith Goldan
Former positions of Keith Goldan
| Companies | Position | Start | End |
|---|---|---|---|
| OPTINOSE, INC. | Director of Finance/CFO | 2016-12-31 | 2022-06-09 |
| FIBROCELL SCIENCE, INC. | Director of Finance/CFO | 2015-03-17 | 2016-12-31 |
| Corporate Secretary | 2015-03-17 | 2015-06-16 | |
| Treasurer | 2015-03-17 | 2016-12-31 | |
| NUPATHE INC | Director of Finance/CFO | 2009-05-03 | 2014-02-20 |
| Investor Relations Contact | 2011-03-21 | 2014-02-20 | |
| Public Communications Contact | 2011-02-14 | 2014-02-20 | |
Cantel Medical (UK) Ltd.
 Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Director of Finance/CFO | - | 2008-10-30 |
| REALM THERAPEUTICS PLC | Director/Board Member | 2004-09-30 | 2008-10-12 |
| Director of Finance/CFO | 2004-09-30 | 2008-10-12 | |
| Century Capital Associates | Founder | - | - |
| Investment Committee Member | - | 2011-06-20 | |
| Corporate Officer/Principal | - | - | |
Biosyn, Inc.
 Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Director of Finance/CFO | - | - |
Training of Keith Goldan
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Robert H. Smith School of Business | Undergraduate Degree |
Statistics
International
| United States | 10 |
| United Kingdom | 2 |
Operational
| Director of Finance/CFO | 7 |
| Treasurer | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Retail Trade |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Biosyn, Inc.
Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
| Century Capital Associates | |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Keith Goldan
- Experience
